Impact of semaglutide withdrawal on cardiometabolic profile and physiology of energy balance: Recovery effects after semaglutide termination – The REST trial study protocol

• Taras Yevusiak,

  Roles Writing – original draft

  Affiliations Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada

  ⨯
• Alanna Weisman,

  Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing

  Affiliations Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada, Division of Endocrinology, University of Toronto, Toronto, Canada

  ⨯
• Ravi Retnakaran,

  Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing

  Affiliations Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada, Division of Endocrinology, University of Toronto, Toronto, Canada

  ⨯
• Sean Wharton,

  Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing

  Affiliation Wharton Medical Clinic Weight and Diabetes Management, Burlington, Ontario, Canada

  ⨯
• Daniel J. Drucker,

  Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing

  Affiliation Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada

  ⨯
• Caroline K. Kramer

  Roles Conceptualization, Funding acquisition, Formal analysis, Methodology, Validation, Writing – original draft

  * E-mail: Caroline.Kramer@sinaihealth.ca

  Affiliations Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada, Division of Endocrinology, University of Toronto, Toronto, Canada

  https://orcid.org/0000-0003-1064-0100

  ⨯